ArticleAlimentary pharmacology & therapeutics2018
Low risk of hepatotoxicity from rifampicin when used for cholestatic pruritus: a cross-disease cohort study.
G J Webb et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this paperpooled itcites it